Q1 2025 Management View CEO Liam Kelly highlighted revenues of $700.7 million for Q1 2025, a decrease of 5% year-over-year on a GAAP basis, aligning with prior guidance. The decline was attributed to ...

Teleflex, a Pennsylvania-based medical device provider, is closing all operations at its Maple Grove facility.

WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced its agreement to acquire BIOTRONIK’s Vascular Intervention ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Teleflex Incorporated ("Teleflex" or "the Company") (NYSE: TFX) ...

A pair of artificial intelligence algorithms from Boston Scientific and Medtronic can be used by the NHS to monitor heart failure patients with implantable devices, but two others from Biotronik ...